Overview
Augmenting Flortaucipir Dosimetry Estimates
Status:
Completed
Completed
Trial end date:
2015-06-01
2015-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Avid Radiopharmaceuticals
Criteria
Inclusion Criteria:- Subjects who passed screening in an Avid-sponsored study in which flortaucipir will be
administered
Exclusion Criteria:
- Subjects who have withdrawn informed consent
- Investigator or sponsor believes it is in the best interest of the subject to be
removed from the trials